Younger adults with lung cancer more likely to have targetable genetic changes, study finds
A new study presented at the World Conference on Lung Cancer reveals that younger adults with non-small cell lung cancer are more likely to possess targetable genetic mutations than older patients. These findings suggest that age-related tumor biology should play a larger role in determining precision treatment strategies.
Why it matters
This research could lead to more effective, personalized cancer therapies for younger patients by moving beyond traditional treatment models.
by University of Miami Leonard M. Miller School of Medicine
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Pixabay/CC0 Public Domain Younger adults with non-small cell lung cancer are significantly more likely than older patients to have genetic alterations that can be matched with targeted therapies, according to a large international study led in part by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
The findings will be presented Sept. 14 in Seoul, Republic of Korea, at the 2026 World Conference on Lung Cancer.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in